TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19254979

Group type: EXPERIMENTAL
Intervention: Sucrose analgesia
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo water
Number of subjects: 240
Study: 17109337

Group type: EXPERIMENTAL
Intervention: AIDSVAX B/E (VaxGen) vaccine
Number of subjects: 2546

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2546
Study: 15009462

Group type: EXPERIMENTAL
Intervention: Oral methionine load
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11571437

Group type: EXPERIMENTAL
Intervention: SRL-CsA-ST
Number of subjects: 525

Group type: COMPARATOR
Intervention: SRL-ST
Number of subjects: 525
Study: 9669720

Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed formula (PHF)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional formula (F)
Number of subjects: 22
Study: 7848545

Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti-inflammatory drugs (NSAIDs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intra-articular glucocorticosteroid therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral steroids and corticotrophin (adrenocorticotrophic hormone)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low dose colchicine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Uricosuric agents (e.g., probenecid)
Number of subjects: 0
Study: 3273865

Group type: EXPERIMENTAL
Intervention: Cefadroxil 30 mg/kg every 24 hours orally for ten days
Number of subjects: 32

Group type: COMPARATOR
Intervention: Penicillin V potassium 15 mg/kg every eight hours orally for ten days
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Cefadroxil
Number of subjects: 32

Group type: COMPARATOR
Intervention: Penicillin
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both therapies
Number of subjects: 32
Study: 30085287

Group type: EXPERIMENTAL
Intervention: Small media intervention (SMI)
Number of subjects: 804

Group type: COMPARATOR
Intervention: Control group (no SMI)
Number of subjects: 804
Study: 27810132

Group type: EXPERIMENTAL
Intervention: Radioguided seed localization (RSL)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Wire localization (WL)
Number of subjects: 298
Study: 25979552

Group type: EXPERIMENTAL
Intervention: Subscapularis-sparing TSA
Number of subjects: 96

Group type: COMPARATOR
Intervention: Traditional TSA
Number of subjects: 96
Study: 25166440

Group type: EXPERIMENTAL
Intervention: Phase I periodontal treatment + NSAID (20 mg tenoxicam tablet once daily for 10 days)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Phase I periodontal treatment + placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups (NSAID and placebo)
Number of subjects: 32
Study: 22596383

Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 7278

Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 7278

Group type: EXPERIMENTAL
Intervention: Any intervention
Number of subjects: 7278
Study: 19660009

Group type: EXPERIMENTAL
Intervention: NVP 200 mg b.i.d. plus > or =2 NRTIs and DRV/r 300/100 mg b.i.d.
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: NVP 200 mg b.i.d. plus > or =2 NRTIs and DRV/r 400/100 mg b.i.d.
Number of subjects: 19

Group type: COMPARATOR
Intervention: NVP 200 mg b.i.d. plus > or =2 NRTIs
Number of subjects: 19
Study: 17454668

Group type: EXPERIMENTAL
Intervention: Dysfunctional Attitude Scale: Form A (DAS‐A)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Young Schema Questionnaire (YSQ)
Number of subjects: 193
Study: 15088722

Group type: EXPERIMENTAL
Intervention: IPS Empress (pressable ceramic)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Duceram (sintered ceramic)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Both IPS and Duceram
Number of subjects: 35
Study: 11506759

Group type: EXPERIMENTAL
Intervention: Teledermatology consultation
Number of subjects: 229

Group type: COMPARATOR
Intervention: Conventional hospital consultation
Number of subjects: 229

Group type: COMPARATOR
Intervention: Conventional hospital appointment
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Teledermatology
Number of subjects: 229
Study: 9626901

Group type: EXPERIMENTAL
Intervention: 100 mg of Mg orally per day for 1 month
Number of subjects: 16

Group type: COMPARATOR
Intervention: No Mg (control group)
Number of subjects: 16
Study: 7833230

Group type: EXPERIMENTAL
Intervention: Lansoprazole (60 mg day-1)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 3046631

Group type: EXPERIMENTAL
Intervention: Dilevalol (100 mg to 800 mg)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Dilevalol (200 mg)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 30795811

Group type: EXPERIMENTAL
Intervention: Multi-component smoking cessation service package (regular motivation by nurse, monthly piCO+ Smokerlyzer test, assistance from trained family member, optional nicotine replacement gum)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Routine service (brief counseling and casual follow-up)
Number of subjects: 319
Study: 27166622

Group type: EXPERIMENTAL
Intervention: Nurses group (n = 147)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Nurses + physician group (n = 151)
Number of subjects: 298
Study: 25517581

Group type: EXPERIMENTAL
Intervention: Occlus-o-Guide
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study: 22526703

Group type: EXPERIMENTAL
Intervention: Modic changes type I at both baseline and 14-month follow-up
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modic changes size
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modic changes developmental path
Number of subjects: 0
Study: 20868965

Group type: EXPERIMENTAL
Intervention: Remifentanil (4 μg/kg IV)
Number of subjects: 47
Study: 18441042

Group type: EXPERIMENTAL
Intervention: 30 minutes of daily training in sit‐to‐stand and leg strengthening exercises for 30 minutes, on weekdays for two weeks, with a physiotherapy assistant
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group received arm therapy
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 30 minutes of daily training in sit‐to‐stand
Number of subjects: 18
Study: 15876493

Group type: EXPERIMENTAL
Intervention: Local anaesthetic solution with morphine (1 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard local anaesthetic solution (articaine plus epinephrine)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 12795735

Group type: EXPERIMENTAL
Intervention: Educational sessions with medical residents (first intervention)
Number of subjects: 813

Group type: EXPERIMENTAL
Intervention: Educational sessions with medical residents (first intervention) and letters from the new doctor (second intervention)
Number of subjects: 813
Study: 10371919

Group type: EXPERIMENTAL
Intervention: One randomly selected implant per patient
Number of subjects: 487

Group type: COMPARATOR
Intervention: Entire material of 1,738 implants
Number of subjects: 487
Study: 8676228

Group type: COMPARATOR
Intervention: Midazolam (1 mg/kg) alone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Midazolam (0.35 mg/kg) and ketamine (5 mg/kg)
Number of subjects: 100
Study: 8475801

Group type: EXPERIMENTAL
Intervention: Fusidic acid
Number of subjects: 13
Study: 3963025

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 100 mg per day
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 150 mg per day
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 200 mg per day
Number of subjects: 35

Group type: COMPARATOR
Intervention: Aspirin 2600 mg per day
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Flurbiprofen (all doses)
Number of subjects: 35
Study: 31634871

Group type: EXPERIMENTAL
Intervention: Ginger (1 gr orally before and after anesthesia)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Dexmedetomidine (25 mg slowly injected before surgery)
Number of subjects: 92
Study: 30170894

Group type: EXPERIMENTAL
Intervention: Filtered-sunlight phototherapy (FSPT)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Intensive electric phototherapy (IEPT)
Number of subjects: 174
Study: 25318186

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of pegaptanib sodium
Number of subjects: 243

Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Pegaptanib sodium
Number of subjects: 243

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 243
Study: 22458638

Group type: EXPERIMENTAL
Intervention: Active pindolol 20 mg retard daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo pindolol
Number of subjects: 0
Study: 21330799

Group type: EXPERIMENTAL
Intervention: Low-fidelity glass globe model training
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (UM training only)
Number of subjects: 32
Study: 17493762

Group type: EXPERIMENTAL
Intervention: Suprathel
Number of subjects: 22

Group type: COMPARATOR
Intervention: Jelonet
Number of subjects: 22
Study: 15625220

Group type: EXPERIMENTAL
Intervention: Treatment Initiation Program (TIP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (pharmacotherapy alone)
Number of subjects: 0
Study: 11879130

Group type: EXPERIMENTAL
Intervention: Patching (initially treated for 6 hours per day or full-time patching)
Number of subjects: 409

Group type: COMPARATOR
Intervention: Atropine (not detailed in the abstract)
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Visual acuity in amblyopic eyes
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Visual acuity in sound eyes
Number of subjects: 409
Study: 10401689

Group type: EXPERIMENTAL
Intervention: Uncorrected cyanotic CHD
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Corrective surgery for cyanotic CHD
Number of subjects: 41

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Post-surgery cyanotic CHD (2 years after surgery)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Acyanotic CHD
Number of subjects: 41
Study: 7645695

Group type: COMPARATOR
Intervention: T-piece circuit (CPAP0)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 5 cmH2O of continuous positive airway pressure (CPAP5)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 10 cmH2O of continuous positive airway pressure (CPAP10)
Number of subjects: 80
Study: 2911999

Group type: EXPERIMENTAL
Intervention: Sodium phytate (2 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sodium phytate (25 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sodium phytate (250 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ascorbic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meat
Number of subjects: 0
Study: 1095159

Group type: EXPERIMENTAL
Intervention: Nebulized lidocaine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no nebulized lidocaine)
Number of subjects: 10
Study: 31347612

Group type: EXPERIMENTAL
Intervention: 300 mg lanadelumab every 2 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 27989681

Group type: EXPERIMENTAL
Intervention: Catheter ablation (CA) plus antiarrhythmic drugs
Number of subjects: 137

Group type: COMPARATOR
Intervention: Antiarrhythmic drugs alone (control group)
Number of subjects: 137
Study: 25849627

Group type: EXPERIMENTAL
Intervention: Visual Inspection with Acetic Acid (VIA)
Number of subjects: 654

Group type: EXPERIMENTAL
Intervention: Visual Inspection with Lugol’s Iodine (VILI)
Number of subjects: 654

Group type: EXPERIMENTAL
Intervention: VILI among women with CD4+ count < 350
Number of subjects: 654

Group type: EXPERIMENTAL
Intervention: VIA among women with CD4+ count < 350
Number of subjects: 654

Group type: EXPERIMENTAL
Intervention: VILI among women with CD4+ count ≥ 350
Number of subjects: 654
Study: 23279405

Group type: EXPERIMENTAL
Intervention: Experienced assessors
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Peer assessment
Number of subjects: 78

Group type: COMPARATOR
Intervention: Digital scanning device (Prepassistant)
Number of subjects: 78
Study: 21562066

Group type: EXPERIMENTAL
Intervention: Fasting glucose before PCI
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Previous myocardial infarction
Number of subjects: 82

Group type: COMPARATOR
Intervention: Traditional and non-traditional risk markers (IL‐1β, IL‐6, TNF‐α, hsCRP, interferon gamma, leptin, IGF‐I, insulin, proinsulin, NT‐proBNP)
Number of subjects: 82
Study: 18253024

Group type: EXPERIMENTAL
Intervention: Information leaflet sent by postal mail
Number of subjects: 860

Group type: COMPARATOR
Intervention: Control group (no leaflet sent)
Number of subjects: 860
Study: 17236635

Group type: EXPERIMENTAL
Intervention: Desflurane/N2O/fentanyl anesthesia with rocuronium 0.6 mg/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol/N2O/fentanyl anesthesia with rocuronium 0.6 mg/kg
Number of subjects: 40
Study: 12851747

Group type: EXPERIMENTAL
Intervention: 25 mg 17beta‐estradiol implant
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo implant
Number of subjects: 40
Study: 10866913

Group type: EXPERIMENTAL
Intervention: Lidocaine 4%
Number of subjects: 63

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 63

Group type: COMPARATOR
Intervention: Air
Number of subjects: 63
Study: 9175118

Group type: EXPERIMENTAL
Intervention: Monetary reward
Number of subjects: 10

Group type: COMPARATOR
Intervention: 'Ok' reinforcer
Number of subjects: 10
Study: 8400558

Group type: COMPARATOR
Intervention: Mn-DPDP at a concentration of 50 mumol/mL
Number of subjects: 20

Group type: COMPARATOR
Intervention: Mn-DPDP at a concentration of 10 mumol/mL
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mn-DPDP
Number of subjects: 20
Study: 3511308

Group type: EXPERIMENTAL
Intervention: 100 mg of metoprolol once daily
Number of subjects: 562

Group type: COMPARATOR
Intervention: 25 mg of hydrochlorothiazide once daily
Number of subjects: 562
Study: 29625120

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the left primary somatosensory cortex (S1) applied repeatedly over five days.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the left primary somatosensory cortex (S1).
Number of subjects: 0
Study: 27255167

Group type: EXPERIMENTAL
Intervention: Improved housing and LLINs
Number of subjects: 800

Group type: COMPARATOR
Intervention: LLINs alone
Number of subjects: 800
Study: 24327175

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) 2 × 2 mg for five consecutive days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22398360

Group type: EXPERIMENTAL
Intervention: Mechanical pump (Group M)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (Group C)
Number of subjects: 100
Study: 20123322

Group type: EXPERIMENTAL
Intervention: Ventilatory threshold (VT) determination using the V-Slope method
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Intra-observer variability assessment
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Inter-observer variability in a second core lab
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Inter-laboratory variability
Number of subjects: 428
Study: 15591079

Group type: EXPERIMENTAL
Intervention: 150 IU of rFSH (group I, n = 26)
Number of subjects: 52

Group type: COMPARATOR
Intervention: 300 IU of rFSH (group II, n = 26)
Number of subjects: 52
Study: 12186198

Group type: EXPERIMENTAL
Intervention: Weekly doses of 2 x 60 mg iron (one tablet each Friday morning and evening)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Daily dose of 1 x 60 mg iron
Number of subjects: 172
Study: 10483942

Group type: EXPERIMENTAL
Intervention: Bradykinin (2.5 microg/min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 30
Study: 8700433

Group type: EXPERIMENTAL
Intervention: Computer conferencing for receiving course assignments and interaction with faculty
Number of subjects: 0
Study: 1927616

Group type: EXPERIMENTAL
Intervention: Nimodipine IV, 2 mg per hour for up to 7 days
Number of subjects: 351

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351
Study: 7011688

Group type: EXPERIMENTAL
Intervention: 3.6 g aspirin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1200 mg azapropazone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Aspirin and azapropazone together
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Azapropazone
Number of subjects: 24
Study: 30930429

Group type: EXPERIMENTAL
Intervention: evolocumab plus standard of care (SOC)
Number of subjects: 556
Study: 30031874

Group type: EXPERIMENTAL
Intervention: Grating acuity at 12 months of age (Teller Acuity Card Test)
Number of subjects: 109
Study: 26576709

Group type: EXPERIMENTAL
Intervention: EBRT plus brachytherapy (40 to 50.4 Gy)
Number of subjects: 20279

Group type: COMPARATOR
Intervention: EBRT alone (75.6 to 81 Gy)
Number of subjects: 20279

Group type: EXPERIMENTAL
Intervention: EBRT plus brachytherapy
Number of subjects: 20279
Study: 24705337

Group type: EXPERIMENTAL
Intervention: MEmory Specificity Training (MEST)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no additional contact)
Number of subjects: 24
Study: 22647290

Group type: EXPERIMENTAL
Intervention: Set of eight revised Forever Free booklets
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Leaflet that has no evidence to suggest it is effective
Number of subjects: 1400
Study: 2826100

Group type: EXPERIMENTAL
Intervention: Medical Qigong (MQ)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 162
Study: 17717604

Group type: EXPERIMENTAL
Intervention: Inhaled NO (iNO; 80 ppm)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 15479686

Group type: EXPERIMENTAL
Intervention: Alicaforsen enema (4 mg/ml)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Alicaforsen enema (2 mg/ml)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 11476359

Group type: EXPERIMENTAL
Intervention: Insulin lispro
Number of subjects: 1184

Group type: COMPARATOR
Intervention: Regular human insulin
Number of subjects: 1184
Study: 9311956

Group type: EXPERIMENTAL
Intervention: Naturally occurring beta-carotene (BC) derived from Dunaliella bardawil (64 mg tBC, 69 mg 9cBC)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (n = 4)
Number of subjects: 12
Study: 7932066

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 3246465

Group type: EXPERIMENTAL
Intervention: Reduced training frequency from 3 days/week to 2 days/week (n = 9), 1 day/week (n = 7), or 0 days/week (n = 2).
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Reduced training frequency from 2 days/week to 1 day/week (n = 12) or 0 days/week (n = 11).
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (n = 9) who did not train.
Number of subjects: 50
Study: 30509224

Group type: EXPERIMENTAL
Intervention: FFIT for Women
Number of subjects: 123
Study: 27684632

Group type: EXPERIMENTAL
Intervention: Warm water intake (200 ml at 98.6°F/37°C in the fourth postoperative hour)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no warm water intake)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Warm water intake
Number of subjects: 60
Study: 23999999

Group type: EXPERIMENTAL
Intervention: Four serum miRNAs (miR‐22, miR‐572, miR‐638, and miR‐1234) used to construct a miRNA signature.
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Combination of the miRNA signature and TNM stage.
Number of subjects: 512
Study: 22624833

Group type: EXPERIMENTAL
Intervention: High-dose clopidogrel
Number of subjects: 1028

Group type: EXPERIMENTAL
Intervention: Standard-dose clopidogrel
Number of subjects: 1028
Study: 20592293

Group type: EXPERIMENTAL
Intervention: Testosterone gel
Number of subjects: 209

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 209
Study: 18246361

Group type: EXPERIMENTAL
Intervention: Hearing aid fitting based on the NAL-RP formula (prescriptive procedure)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparative fitting procedure (optimizing speech intelligibility scores)
Number of subjects: 0
Study: 17206944

Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol 600 IU/day plus ascorbic acid 500 mg/day (group B)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Balanced calorie diet and physical exercise (group A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (group A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Alpha-tocopherol and ascorbic acid (group B)
Number of subjects: 90
Study: 12833187

Group type: EXPERIMENTAL
Intervention: Pressure threshold inspiratory muscle training
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Targeted resistive inspiratory muscle training
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study: 10370197

Group type: EXPERIMENTAL
Intervention: DLPC liposomes
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: DPPC liposomes
Number of subjects: 11
Study: 8909662

Group type: EXPERIMENTAL
Intervention: i.v. prochlorperazine 0.1 mg.kg‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: i.m. prochlorperazine 0.2 mg.kg‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: i.v. ondansetron 0.06 mg.kg‐1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1875403

Group type: EXPERIMENTAL
Intervention: Diet
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Diet plus goal setting
Number of subjects: 40

Group type: COMPARATOR
Intervention: Medication
Number of subjects: 40
Study: 6362091

Group type: EXPERIMENTAL
Intervention: Immediate heparinization
Number of subjects: 45

Group type: COMPARATOR
Intervention: No immediate anticoagulation
Number of subjects: 45
Study: 31434094

Group type: EXPERIMENTAL
Intervention: Interventional AVM treatment (surgical resection, endovascular therapy, stereotactic radiosurgery)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical management (implied control)
Number of subjects: 0
Study: 29574974

Group type: EXPERIMENTAL
Intervention: Everolimus 2.25-3 mg BID in transplant patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Everolimus 3.75 mg BID for oncological indications
Number of subjects: 0
Study: 27187464

Group type: EXPERIMENTAL
Intervention: Ultra Rice(®) (UR(®)) fortified with iron, zinc, thiamin and folic acid
Number of subjects: 99

Group type: COMPARATOR
Intervention: Polished rice
Number of subjects: 99